NCT06651944

Brief Summary

The goal of this clinical trial is to observe study participants' comfort and fit of their aligners with occlusal blocks, as well as evaluate the engagement of the blocks using the Invisalign® System with mandibular advancement featuring occlusal blocks

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Feb 2024

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Feb 2024Dec 2026

Study Start

First participant enrolled

February 14, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 17, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 22, 2024

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

October 23, 2024

Status Verified

October 1, 2024

Enrollment Period

2.9 years

First QC Date

October 17, 2024

Last Update Submit

October 21, 2024

Conditions

Keywords

Class II MalocclusionMandibular AdvancementInvisalignOrthodonticsOcclusal BlocksGrowing Patients

Outcome Measures

Primary Outcomes (1)

  • Comfort and fit

    Measured using quality of life surveys at the insertion, interim, and end of study visits. Measured on a scale which the subject rates from 1-Always to 5-Never on their current experience.

    Through the study completion of up to 2 years

Secondary Outcomes (1)

  • Class II correction

    Through the study completion of up to 2 years

Other Outcomes (1)

  • Class II correction

    Through the study completion of up to 2 years

Study Arms (1)

Invisalign® System with Mandibular Advancement

EXPERIMENTAL

all participants will receive the study device

Device: Invisalign® System with mandibular advancement featuring occlusal blocks

Interventions

Class II correction using the Invisalign® System with mandibular advancement featuring occlusal blocks

Invisalign® System with Mandibular Advancement

Eligibility Criteria

Age10 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Subject must be eligible for Invisalign treatment with mandibular advancement

You may not qualify if:

  • Subject's dentition not compatible with device or allergy to device materials
  • Subject who is pregnant, has active caries, periodontal disease, TMD, root resorption, has HAE (hereditary angioedema), has been diagnosed with epilepsy or any other seizure disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Astra Orthodontics

Richmond, British Columbia, BC V7C 5L9, Canada

RECRUITING

MacKenzie Orthodontics

Saint John, New Brunswick, E2L 1G5, Canada

RECRUITING

Discover Orthodontics

Brampton, Ontario, L6Z 4N5, Canada

RECRUITING

MeSH Terms

Conditions

Overbite

Condition Hierarchy (Ancestors)

Malocclusion, Angle Class IIMalocclusionTooth DiseasesStomatognathic Diseases

Central Study Contacts

Allison Mossing

CONTACT

Karen Srour

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2024

First Posted

October 22, 2024

Study Start

February 14, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

October 23, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Data is planned to be shared with Sponsor and Investigators only

Locations